History and Mission of Khavinson Peptides Foundation

Global Aging Trends and Societal Challenges

The process of aging is a naturally predetermined evolutionary mechanism. As UN data illustrates, the number of elderly individuals is growing worldwide, both in total numbers and as a percentage of the population. This trend will inevitably lead to complications and burdens on public health and social structures. Given this global aging phenomenon, it becomes essential to explore new methods to prolong the working life, slow premature aging, and prevent age-related diseases.

Discovery of Peptide Signalling Molecules

A breakthrough discovery has recently been made in the fields of biology and medicine. It has been revealed that certain vital capacities of the human organism can be enhanced by 20 – 42% through experimentation. This discovery involves a new class of peptide signaling molecules, which can epigenetically regulate gene expression, protein synthesis, and organ function. These peptides have shown the ability to reduce tumor incidence and increase average lifespan in animal studies. Additionally, peptide administration has been shown to normalize human bodily functions, slowing aging and reducing mortality.

Peptide Extractions and Synthesis by Professor Khavinson

From 1973 to 2014, Professor V. Kh. Khavinson and his team extracted over 20 complexes of physiologically active peptides from various organs and synthesized 17 others from amino acids. These included dipeptides, tripeptides, and tetrapeptides, which have been patented across multiple countries, including the USA, Canada, Australia, Europe, Japan, Korea, Israel, and others.

Approval and Medical Usage of Peptide Preparations

After several decades of research and clinical studies, six medicinal peptide preparations were approved for medical use in the USSR, Russia, and later, in CIS countries by the Ministry of Health (comparable to the USA’s FDA). These were primarily utilized by military medical services and include:

• Thymalin: immunity regulator from the thymus
• Epithalamin: endocrine function regulator from the pineal gland
• Cortexin: brain function regulator from the cerebral cortex
• Prostatilen: prostate function regulator from the prostate gland
• Retinalamin: retina function restorer for degenerative diseases
• Thymogen: immunity regulator, a dipeptide (EW) first extracted from ‘Thymalin’, then synthesized These became known as pharmaceuticals created using Khavinson peptides technology.

Scientific Evidence and Effectiveness of Peptide Drugs

Research backed by 30 years of experience demonstrates the high effectiveness of these peptide drugs across various medical fields, including neurology, therapy, and ophthalmology. Over the past 15 years, active scientific collaboration among researchers, doctors, and pharmacologists in the Russian Federation and CIS countries has facilitated the further incorporation of peptides into daily practices of specialists across multiple disciplines.

Applications in Industrial, Military, and Space Medicine

Due to their proven efficacy, peptide-based products and biotechnologies are now utilized in industrial, military, and space medicine sectors. These medications have been employed in the complex treatment of victims of earthquakes, nuclear submarine accidents, and the Chernobyl nuclear power plant disaster. Continued studies of these bioregulators’ effectiveness on humans have conclusively demonstrated their capacity to increase the human body’s life resources and significantly decrease patient mortality over a 15-year study period.